HEALTH CARE

Divide and Conquer: Cytocare Inc., an Irvine medical device manufacturer, is diversifying when others are consolidating.

The company, which already has one wholly owned subsidiary that manufactures a machine that pulverizes kidney stones, is splitting into three divisions to oversee its diversification efforts more carefully.

Under its endourology division, the company will sell its line of catheters and lasers for use in opening blockages of the prostate gland.

Its medical biology division is developing ways to diagnose prostate cancer and other diseases, while a third division, the small molecule pharmaceuticals division, is working on new drugs to treat prostate cancer and other prostate diseases, such as enlargement of the prostate.

“We have tried to position ourselves not only to continue to provide good science, but to respond to the reformation of the health care system under the Clinton Administration,” said Cytocare Chief Executive Errol Payne.